As predicted, government stimulus spending intended to jumpstart the global economy did the trick for Bruker Corp. (NSDQ:BRKR) in the second half of 2009, as the company recorded nearly $70 million in sales derived from global stimulus packages.
Billerica, Mass.-based Bruker manufactures analytic tools such as X-ray systems, spectrometers and magnetic resonance imaging instruments. The company has been saying since early 2009 that it expected to profit from the various stimulus programs being implemented by governments across the globe to stimulate the faltering economy.
The company said that all five of its divisions received stimulus orders in the second half of 2009, the bulk of which for pre-clinical MRI, mass spectrometry and X-ray systems. The average sales price was around $500,000 per system, and the orders will likely be reflected as revenues during 2010 and into the first half of 2011. Company officials also said they expect to receive more stimulus-funded orders in the coming months as well.
Last July, Bruker CEO Frank Laukien said he expected the firm to record about $200 million from stimulus orders over the next several quarters.
